Naja, warum sollte der Preis nicht weiterhin steigen? CytoDyns Medikament zeigte bisher gute Resultate und im Gegensatz zu anderen Unternehmen sind sie schon in Phase2. Deshalb ist es doch recht wahrscheinlich, dass weiterhin positive News kommen und "bald" Phase3 eingeleitet werden könnte.
Aktuell von der Website vom 31.03. 6am EDT:
"(...) today that the U.S. Food and Drug Administration (FDA) just provided clearance for initiation of a Phase 2 trial with CytoDyn’s leronlimab to treat COVID-19 patients with mild to moderate indications. The Company’s investigational new drug, leronlimab, has been administered to 10 severely ill patients with COVID-19 at a leading medical center in the New York City area under an emergency IND recently granted by the FDA. "
Aktuell von der Website vom 31.03. 6am EDT:
"(...) today that the U.S. Food and Drug Administration (FDA) just provided clearance for initiation of a Phase 2 trial with CytoDyn’s leronlimab to treat COVID-19 patients with mild to moderate indications. The Company’s investigational new drug, leronlimab, has been administered to 10 severely ill patients with COVID-19 at a leading medical center in the New York City area under an emergency IND recently granted by the FDA. "